133 related articles for article (PubMed ID: 34538850)
1. Outcome and Toxicity of Proton Therapy for Vestibular Schwannoma: A Cohort Study.
Koetsier KS; Hensen EF; Niemierko A; Dewyer NA; Chapman PH; Lamba N; Bussière MR; van Vulpen M; McKenna MJ; Loeffler JS; Shih HA
Otol Neurotol; 2021 Dec; 42(10):1560-1571. PubMed ID: 34538850
[TBL] [Abstract][Full Text] [Related]
2. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity.
Weber DC; Chan AW; Bussiere MR; Harsh GR; Ancukiewicz M; Barker FG; Thornton AT; Martuza RL; Nadol JB; Chapman PH; Loeffler JS
Neurosurgery; 2003 Sep; 53(3):577-86; discussion 586-8. PubMed ID: 12943574
[TBL] [Abstract][Full Text] [Related]
3. Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series.
Douwes JPJ; Koetsier KS; van Dam VS; Plotkin SR; Barker FG; Welling DB; Jansen JC; Hensen EF; Shih HA
Curr Oncol; 2023 Mar; 30(3):3473-3483. PubMed ID: 36975476
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.
Putz F; Müller J; Wimmer C; Goerig N; Knippen S; Iro H; Grundtner P; Eyüpoglu I; Rössler K; Semrau S; Fietkau R; Lettmaier S
Strahlenther Onkol; 2017 Mar; 193(3):200-212. PubMed ID: 27928625
[TBL] [Abstract][Full Text] [Related]
5. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
[TBL] [Abstract][Full Text] [Related]
6. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
7. Labyrinthine Fluid Signal Intensity on T2-Weighted MR Imaging in Patients With Vestibular Schwannomas Undergoing Proton Radiotherapy: A Longitudinal Assessment.
Koetsier KS; Mehan WA; Buch K; Welling DB; van Benthem PPG; Hensen EF; Shih HA
Otol Neurotol; 2023 Feb; 44(2):183-190. PubMed ID: 36624600
[TBL] [Abstract][Full Text] [Related]
8. Trigeminal neuropathy in vestibular schwannoma: a treatment algorithm to avoid long-term morbidity.
Galloway L; Palaniappan N; Shone G; Hayhurst C
Acta Neurochir (Wien); 2018 Apr; 160(4):681-688. PubMed ID: 29344779
[TBL] [Abstract][Full Text] [Related]
9. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
10. Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption.
Sawamura Y; Shirato H; Sakamoto T; Aoyama H; Suzuki K; Onimaru R; Isu T; Fukuda S; Miyasaka K
J Neurosurg; 2003 Oct; 99(4):685-92. PubMed ID: 14567604
[TBL] [Abstract][Full Text] [Related]
11. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
12. Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series.
Benghiat H; Heyes G; Nightingale P; Hartley A; Tiffany M; Spooner D; Geh JI; Cruickshank G; Irving RM; Sanghera P
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):309-15. PubMed ID: 24636634
[TBL] [Abstract][Full Text] [Related]
13. Cochlear implantation after radiosurgery for vestibular schwannoma.
Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
[TBL] [Abstract][Full Text] [Related]
14. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
[TBL] [Abstract][Full Text] [Related]
16. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes in patients treated with CyberKnife radiosurgery for vestibular schwannoma.
Vivas EX; Wegner R; Conley G; Torok J; Heron DE; Kabolizadeh P; Burton S; Ozhasoglu C; Quinn A; Hirsch BE
Otol Neurotol; 2014 Jan; 35(1):162-70. PubMed ID: 24335934
[TBL] [Abstract][Full Text] [Related]
18. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Facial Nerve Paresis Following Gamma Knife for Vestibular Schwannoma.
Lerner DK; Lee D; Naples JG; Brant JA; Bigelow D; Alonso-Basanta M; Ruckenstein MJ
Otol Neurotol; 2020 Jan; 41(1):e83-e88. PubMed ID: 31743296
[TBL] [Abstract][Full Text] [Related]
20. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
